Leiner Sales, Gross Profit Advances Reflect Restructuring Initiatives
This article was originally published in The Tan Sheet
Executive Summary
Leiner Health Products' ongoing restructuring efforts appear to be paying dividends as the firm's net sales jumped 7.2% to $139.5 mil. for the first quarter ended June 30.
You may also be interested in...
Leiner Chapter 11 Plan To Include New Capital, Credit, Debt Restructuring
Leiner Health Products will use a tentative $20 mil. equity investment to support ongoing operations as it prepares to seek Chapter 11 protection in early 2002, the company stated
Leiner
Supplement/OTC drug manufacturer reaches agreement in principle with lenders to extend forbearance deadline until Sept. 28. Extension enables company to continue push toward permanent financial restructuring plan (1"The Tan Sheet" Aug. 20, p. 9)
Leiner Restructuring Builds On SKU Reductions, Customer "Rationalization"
Leiner Health Products is cutting approximately 40% of its SKUs as part of a restructuring plan designed to turn around the dietary supplement and OTC drug marketer's ailing financials.